PubRank

O Sitbon

Author PubWeight™ 62.80‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study. Lancet 2001 6.88
2 Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Eur Respir J 2010 2.90
3 Survival with first-line bosentan in patients with primary pulmonary hypertension. Eur Respir J 2005 2.83
4 Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med 1995 2.76
5 Splenectomy and chronic thromboembolic pulmonary hypertension. Thorax 2005 2.03
6 Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension. Eur Respir J 2009 1.85
7 [Guidelines for the diagnosis and treatment of pulmonary hypertension]. Rev Mal Respir 2010 1.74
8 Chronic thromboembolic pulmonary hypertension. Eur Respir J 2004 1.74
9 Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases. Eur Respir J 2007 1.51
10 Pulmonary vascular disorders in portal hypertension. Eur Respir J 1998 1.44
11 Pulmonary veno-occlusive disease. Eur Respir J 2009 1.37
12 Long term imatinib treatment in pulmonary arterial hypertension. Thorax 2006 1.32
13 BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives. Eur Respir J 2002 1.31
14 Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis. Thorax 2005 1.29
15 Severe pulmonary hypertension in histiocytosis X. Am J Respir Crit Care Med 2000 1.23
16 Primary pulmonary hypertension associated with the use of fenfluramine derivatives. Chest 1998 1.22
17 Risk factors for pulmonary arterial hypertension. Clin Chest Med 2001 1.20
18 Heart rate responses during the 6-minute walk test in pulmonary arterial hypertension. Eur Respir J 2006 1.11
19 Pathobiology of pulmonary hypertension. The role of platelets and thrombosis. Clin Chest Med 2001 1.11
20 Noncardiothoracic nonobstetric surgery in mild-to-moderate pulmonary hypertension. Eur Respir J 2009 1.08
21 Treatment of pulmonary hypertension secondary to connective tissue diseases. Thorax 1999 1.08
22 Treatment of severe pulmonary hypertension secondary to connective tissue diseases with continuous IV epoprostenol (prostacyclin). Chest 1998 1.08
23 Clinical significance of the pulmonary vasodilator response during short-term infusion of prostacyclin in primary pulmonary hypertension. Circulation 1996 1.07
24 Fatal dissection of the pulmonary artery in pulmonary arterial hypertension. Eur Respir Rev 2009 1.00
25 Imbalance between platelet vascular endothelial growth factor and platelet-derived growth factor in pulmonary hypertension. Effect of prostacyclin therapy. Am J Respir Crit Care Med 2000 1.00
26 Changes in exercise haemodynamics during treatment in pulmonary arterial hypertension. Eur Respir J 2008 0.98
27 Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease. Eur Respir J 2009 0.92
28 Improvement of von Willebrand factor proteolysis after prostacyclin infusion in severe pulmonary arterial hypertension. Circulation 2000 0.91
29 Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesis. Eur Respir J 2002 0.90
30 [Surgical treatment of chronic thromboembolic pulmonary hypertension]. Presse Med 2005 0.89
31 Occult alveolar haemorrhage in pulmonary veno-occlusive disease. Eur Respir J 2006 0.86
32 The association between resting and mild-to-moderate exercise pulmonary artery pressure. Eur Respir J 2011 0.85
33 Fenfluramine-like cardiovascular side-effects of benfluorex. Eur Respir J 2009 0.84
34 Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension. Eur Respir J 2008 0.84
35 Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study. Eur Respir J 1999 0.83
36 [Pulmonary hypertension associated with connective tissue diseases]. Rev Med Interne 2002 0.82
37 Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertension. Arthritis Rheum 2012 0.82
38 [Clinical, haemodynamic and genetic features of familial pulmonary arterial hypertension]. Rev Mal Respir 2004 0.81
39 Reversibility of pulmonary arterial hypertension in HIV/HHV8-associated Castleman's disease. Eur Respir J 2005 0.78
40 Goal-oriented therapy in pulmonary veno-occlusive disease: a word of caution. Eur Respir J 2009 0.78
41 Implementing the ESC/ERS pulmonary hypertension guidelines: real-life cases from a national referral centre. Eur Respir Rev 2009 0.78
42 [Genetics of pulmonary arterial hypertension: recent data and practical applications]. Rev Mal Respir 2005 0.78
43 [Biomarkers as prognostic factors in pulmonary arterial hypertension. Rationale and study design]. Rev Mal Respir 2004 0.77
44 [Pulmonary hypertension and obesity]. Rev Pneumol Clin 2002 0.77
45 [Pulmonary arterial hypertension due to tumor emboli]. Rev Mal Respir 2007 0.76
46 [Pulmonary artery hypertension associated with connective tissue diseases]. Presse Med 2003 0.76
47 Current management approaches to portopulmonary hypertension. Int J Clin Pract Suppl 2011 0.76
48 Auranofin in steroid dependent asthma. Thorax 1992 0.75
49 Systemic lupus erythematosus-associated PAH: is targeting inflammation the key to success? Eur Respir Rev 2011 0.75
50 Pulmonary arterial hypertension: combination therapy in the modern management era. Eur Respir Rev 2010 0.75
51 Intravenous iloprost for pulmonary arterial hypertension: still waiting for evidence. Eur Respir J 2009 0.75
52 [Porto-pulmonary hypertension]. Rev Mal Respir 2006 0.75
53 Novel therapeutic perspectives in pulmonary arterial hypertension. Eur Respir J 2003 0.75
54 Successful treatment of disseminated cryptococcosis with high-dose oral fluconazole. AIDS 1993 0.75
55 [Treatment of pulmonary arterial hypertension]. Presse Med 2005 0.75
56 [Native renal hydatidosis. A rare cause of prolonged fever]. Presse Med 1991 0.75
57 [Surgical treatment of post-embolism pulmonary hypertension]. Rev Pneumol Clin 2004 0.75
58 [Diagnosis and classification of pulmonary arterial hypertension]. Presse Med 2005 0.75
59 [Acute lipid pneumopathy]. Arch Pediatr 1995 0.75
60 [Chronic pulmonary thromboembolism revealing beta-thalassemia intermedia after splenectomy]. Rev Med Interne 2006 0.75
61 [Pulmonary arterial hypertension of chronic thromboembolic origin; therapeutic indications]. Arch Mal Coeur Vaiss 1994 0.75
62 [Postembolic pulmonary hypertension]. Rev Mal Respir 2007 0.75
63 [A case of severe colitis with positive hemocultures for Shigella flexneri]. Presse Med 1987 0.75
64 [Pulmonary arterial hypertension of chronic thrombo-embolic origin. 70 patients]. Presse Med 1994 0.75
65 [Treatments for pulmonary arterial hypertension]. Rev Med Interne 2004 0.75
66 [Pulmonary arterial hypertension]. Rev Mal Respir 2005 0.75
67 Cirrhosis ameliorates monocrotaline-induced pulmonary hypertension in rats. Eur Respir J 2009 0.75
68 [Risk factors in venous thromboembolism]. Presse Med 1998 0.75
69 [HIV-related pulmonary arterial hypertension]. Rev Mal Respir 2012 0.75